Interleukin-17: A Revisited Study

Oppenheim J.J. Ruscetti F.W. , 1997. Cytokines. In Medical Immunology, 9th ed. Stites D.P. Terr A.I. Parslow T.G. , Appleton and Lange Stamford, Connecticut, p. 146.

Kempuraj D. Frydas S. Kandere K. Madhappan B. Letourneau R. Christodoulou S. Boucher W. Riccioni G. Conti P. Theoharides T. C. , 2003. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol. 16:95.

Garbuglia A.R. Iezzi T. Capobianchi M.R. Pignoloni P. Pulsoni A. Sourdis J. Pescarmona E. Vitolo D. Mandelli F. , 2003. Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection. Int. J. Immunopathol. Pharmacol. 16:109.

Mazzoccoli G. Grilli M. Carughi S. Puzzolante F. De Cata A. La Viola M. Giuliani A. Urbano N. Tarquini R. Perfetto F. , 2003. Immune system alterations in lung cancer patients. Int. J. Immunopathol. Pharmacol. 16:167.

Roux M.E. Marquez M.G. Olmos S. Frecha C.A. Florin-Christensen A. , 2003. Compartmentalisation between Gut and Lung mucosae in a model of secondary immunodeficiency. Effect of thymomodulin. Int. J. Immunopathol. Pharmacol. 16:151.

He S.C. Qiao N. Sheng W. , 2003. Neurobehavioral, autonomic nervous function and lymphocyte subsets among aluminum electrolytic workers. Int. J. Immunopathol. Pharmacol. 16:139.

Di Gioacchino M. Verna N. Cavalluci E. Paolini F. Caruso R. Grana M. Schiavone C. Di Iorio A. Ramando S. Reale M. Paganelli R. Theoharides T. C. , 2002. Steroid and antihistamines modulate RANTES release in cultures peripheral blood mononuclear cells of atopic patients. Int. J. Immunopathol. Pharmacol. 15:27.

Conti P. Reale M. Barbacane R.C. Castellani M.L. Orso C. , 2002. Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee. Immunol. Lett. 80:105.

Arena A. Enzo B. Enrico G. Marco B. Graziella R. , 2003. Specific immunotheraphy of allergic diseases: A three years perspective observational study. Int. J. Immunopathol. Pharmacol. 16:277.

Biswas S.K. Sodhi A. , 2002. Effect of monocyte chemoattractant protein-1 on murine bone marrow cells: Proliferation, colony forming ability signal transduction pathway involved. Int. J. Immunopathol. Pharmacol. 15:183.

Conti P. Reale M. Barbacane R.C. Letorneau R. Theoharides T.C. , 1998. Intramuscolar injection of RANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: Lack of effects in genetically mast cell-deficient W/Wv mice. FASEB J. 12:1693.

Theoharides T.C. 2002. Mast cells and stress. A psychoneuroimmunological perspective. J. Clin. Psychopharmacol. 22:103.

Parrella O. Parrella M. Cusumano V. Ibello U. Sbreglia C. De Sena R. Perrella A. , 2002. Interleukin-10 and transforming growth factor beta 1 in hepatic fibrosis. Int. J. Immunopathol. Pharmacol. 15:243.

Huang M. Berry J. Kandere K. Lytinas M. Karalis K. Theoharides T.C. , 2002. Mast cell deficient w/w^v mice lack stress-induced increse in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int. J. Immunopathol. Pharmacol. 15:249.

Lee D.M. Friend D.S. Gurish M.F. Benoist C. Mathis D. Brenner M.B. , 2002. Mast cells: A cellular link between autoantibodies and inflammatory arthritis. Sciences 297:1689.

Bruno G. Andreozzi P. Graf U. Santangelo G. Barucco M. Bruno A. Bracchitta S. , 2002. Cetirizine, a second-generation H1 antagonist, modulates RANTES and MCP-1 levels in allergic rhinitis. Int. J. Immunopathol. Pharmacol. 15:113.

Riccioni G. Della Vecchia R. Castronuovo M. Di Pietro V. Spoltore R. De Benedictis M. Di Iorio A. Di Gioacchino M. Guagnano M.T. , 2002. Bronchial hyperresponsiveness in adults with seasonal and perennial rhinitis: A link for asthma and rhinitis? Int. J. Immunopathol. Pharmacol. 15:69.

Fossiez F. Djossou O. Chomarat P. , 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183:2593.

Frydas S. Madhappan B. Kempuraj D. , 2002. Some aspects of parasitology and immunology in general medicine. Int. J. Immunopathol. Pharmacol. 15:165.

Chiappini E. Peruzzi M. Galli L. Calabri G. de Martino M. , 2002. Dose-related IL-6 overproduction by phenobarbital-incubated peripheral blood mononuclear cells in a child with anticonvulsant hypersensitivity syndrome. Int. J. Immunopathol. Pharmacol. 15:239.

Macrì M.A. Sr. Di Luzio Di Luzio S. , 2002. Biological effects of electromagnetic fields. Int. J. Immunopathol. Pharmacol. 15:95.

Rallis T.S. Frydas S. Soubasis N. Adamama-Moraitou K.K. Tontis D. , 2002. Monocyte chemotactic protein – 1 in a randomized placebo-controlled study of canine plasmacytic-lymphocytic colitis. Int. J. Immunopathol. Pharmacol. 15:107.

Yoshino S. Hayashi H. Taneda S. Takano H. Sagai M. Mori Y. , 2002. Effects of diesel exhaust particle extracts on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol. 15:13.

Gioia C. Agrati C. Goletti D. Vincenti D. Carrara S. Amicosante M. Casarini M. Giosue S. Puglisi G. Rossi A. Colizzi V. Pucillo L.P. Poccia F. , 2003. Different cytokine production and effector/memory dynamics of ab⁺ or gd⁺ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis. Int. J. Immunopathol. Pharmacol. 16:247.

Camera E. Lisby S. Dell'Anna M.L. Santucci B. Paganelli R. Baadsgaard O. Picardo M. , 2003. Mononuclear cell antioxidant pattern and skin reactivity to irritants. Int. J. Immunopathol. Pharmacol. 16:49.

Longhi C. Penta M. Conte M.P. Girmenia C. Seganti L. , 2003. Heterogeneity of virulence-related properties in listeria monocytogenes strains isolated from patients with haematological malignancies. Int. J. Immunopathol. Pharmacol. 16:119

Mastrangelo G. Fornasa C. Veller Pavanello S. Marcer G. Lazzaro M. Milan G. Fadda E. Fedeli U. Clonfero E. , 2003. Polyaromatic hydrocarbons administered in humans by dermal route increase total IgE. Int. J. Immunopathol. Pharmacol. 16:145

Vojdani A. Pangborn J.B. Vojdani E. Cooper E.L. , 2003. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopathol. Pharmacol. 16:189

Vecchiet J. Dalessandro M. Travasi F. Falasca K. Di Iorio A. Schiavone C. Zingariello P. Di Ilio E. Pizzigallo E. Paganelli R. , 2003. Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. Int. J. Immunopathol. Pharmacol. 16:157

Moseley T.A. Haudenschild D.R. Rose L. Reddi AH ., 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155.

Hurst S.D. Muchamuel T. Gorman D.M. Gilbert J.M. Clifford T. Kwan S. Menon S. Seymour B. Jackson C. Kung TT. Brieland J.K. Zurawski S.M. Chapman R.W. Zurawski G. Coffman R.L. , 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: In vivo function of the novel cytokine IL-25. J. Immunol. 169:443

Aarvak T. Chabaud M. Miossec P. Natvig J.B. , 1999. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J. Immunol. 162:1246.

Albanesi C. Scarponi C. Cavani A. Federici M. Nasorri F. Girolomoni G. , 2000. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J. Invest. Dermatol. 115:81

Moore E.E. Presnell S. Garrigues U. Guilbot A. LeGuern E. Smith D. Yao L. Whitmore T.E. Gilbert T. Palmer T.D. Horner P.J. Kuestner R.E. , 2002. Expression of IL-17B in neurons and evaluation of its possible role in the chromosome 5q-linked form of Charcot-Marie-Tooth disease. Neuromuscul. Disord. 12:41.

Shi Y. Ullrich S.J. Zhang J. Connolly K. Grzegorzewski K.J. Barber M.C. Wang W. Wathen K. Hodge V. Fisher C.L. Olsen H. Ruben S.M. Knyazev I. Cho Y.H. Kao V. Wilkinson K.A. Carrell J.A. Ebner R. , 2000. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J. Biol. Chem. 275:19167.

Li H. Chen J. Huang A. Stinson J. Heldens S. Foster J. Dowd P. Gurney A.L. Wood W.I. , 2000. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc. Natl. Acad. Sci. USA 97:773.

Starnes T. Broxmeyer H.E. Robertson M.J. Hromas R. , 2002. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. 169:642.

Lee J. Ho W.H. Maruoka M. Corpuz R.T. Baldwin D.T. Foster J.S. Goddard A.D. Yansura D.G. Vandlen R.L. Wood W.I. Gurney A.L. , 2001. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rhl. J. Biol. Chem. 276:1660.

Pan G. French D. Mao W. Maruoka M. Risser P. Lee J. Foster J. Aggarwal S. Nicholes K. Guillet S. Schow P. Gurney A.L. , 2001. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J. Immunol. 167:6559.

Starnes T. Robertson M.J. Sledge G. Kelich S. Nakshatri H. Broxmeyer H.E. Hromas R. , 2001. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J. Immunol. 167:4137.

Faour W.H. Mancini A. He Q.W. Di Battista J.A. , 2003. T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: Role of distal sequences in the 3′-untranslated region of COX-2 mRNA. J. Biol. Chem. 278:26897.

Kerins C.A. Spears R. Bellinger L.L. Hutchins B. , 2003. The prospective use of COX-2 Inhibitors for the treatment of temporomandibular joint inflammatory disorders. Int. J. Immunopathol. Pharmacol. 16(S):1.

Picado C. 2003. COX-2 specific inhibitors in NSAID-intolerant patients. Int. J. Immunopathol. Pharmacol. 16(S):11.

Van der Bijl P. Van der Bijl P. Jr , 2003. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors. Int. J. Immunopathol. Pharmacol. 16(S):17.

Pronai L. Hritz I. Molnar B. Herszenyi L. Tulassay Z. , 2003. COX-2 selective inhibitors (COXIBS) –gastrointestinal safety. Int. J. Immunopathol. Pharmacol. 16(S):23.

Giovannini M.G. Scali C. Prosperi C. Bellucci A. Pepeu G. Casamenti F. , 2003. Experimental brain inflammation and neurodegeneration as model of Alzheimer's Disease: Protective effects of selective COX-2 inhibitors. Int. J. Immunopathol. Pharmacol. 16(S):31.

Lang S. Zeidler R. , 2003. Immune restoration in head and neck cancer patients via cyclooxygenase inhibition: An update. Int. J. Immunopathol. Pharmacol. 16(S):41.

Capone M.L. Tacconelli S. Sciulli M.G. Patrignani P. , 2003. Clinical pharmacology of selective COX-2 inhibitors. Int. J. Immunopathol. Pharmacol. 16(S):49.

Ramsay R.G. Ciznadija D. Vanevski M. Mantamadiotis T. , 2003. Transcriptional regulation of cyclooxygenase expression: Three pillars of control. Int. J. Immunopathol. Pharmacol. 16(S):59.

Goodman S. B. Ma T. Genovese M. Smith R. Lane . 2003. COX-2 selective inhibitors and bone. Int. J. Immunopathol. Pharmacol. 16:201.

Pietropaolo V. Fioriti D. Simeone P. Videtta M. Di Taranto C. Arancio A. Orsi N. Degener A.M. , 2003. Detection and sequence analysis of human polyomaviruses DNA from autoptic samples of HIV-1 positive and negative subjects. Int. J. Immunopathol. Pharmacol. 16:269.

Fioriti D. Pietropaolo V. Dal Forno S. Laurenti C. Chiarini F. Degener A.M. , 2003. Urothelial bladder carcinoma and viral infections: Different association with human polyomaviruses and papillomaviruses. Int. J. Immunopathol. Pharmacol. 16:283.

Trubiani O. Salvolini E. Staffolani R. Di Primio R. Mazzanti L. , 2003. DMSO modifies structural and functional properties of RPMI-8402 cells by promoting programmed cell death. Int. J. Immunopathol. Pharmacol. 16:253.

Ramakrishnan R. Nazer M.Y. Suthanthirarajan N. Namasivayam A. , 2003. An experimental analysis of the catecholamines in hyperglycemia and acidosis induced rat brain. Int. J. Immunopathol. Pharmacol. 16:233.

Frydas S. Hatzistilianou M. Karagouni E. Madhappan B. D'Orazio N. Riccioni G. Conti F. Carratelli G. Kempuraj D. , Chemokines and parasites. Int. J. Immunopathol. Pharmacol. 16:221.

Addolorato G. Ancona C. Capristo E. Gasbarrini G. , Metadoxine in the treatment of acute and chronic alcoholism: A review. Int. J. Immunopathol. Pharmacol. 16:207.

Kaneider N.C. Kaser A. Tilg H. Ricevuti G. Wiedermann C.J. , 2003. CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int. J. Immunopathol. Pharmacol. 16:225.